226 related articles for article (PubMed ID: 15855486)
1. Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum.
Sierra JM; Martinez-Martinez L; Vázquez F; Giralt E; Vila J
Antimicrob Agents Chemother; 2005 May; 49(5):1714-9. PubMed ID: 15855486
[TBL] [Abstract][Full Text] [Related]
2. Wide spread and diversity of mutation in the gyrA gene of quinolone-resistant Corynebacterium striatum strains isolated from three tertiary hospitals in China.
Wang Y; Shi X; Zhang J; Wang Y; Lv Y; Du X; ChaoLuMen Q; Wang J
Ann Clin Microbiol Antimicrob; 2021 Oct; 20(1):71. PubMed ID: 34598679
[TBL] [Abstract][Full Text] [Related]
3. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
4. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
5. Bacteremia caused by Corynebacterium amycolatum with a novel mutation in gyrA gene that confers high-level quinolone resistance.
Yoon S; Kim H; Lee Y; Kim S
Korean J Lab Med; 2011 Jan; 31(1):47-8. PubMed ID: 21239871
[TBL] [Abstract][Full Text] [Related]
6. [Activity of new quinolones against clinical isolates of Corynebacterium species].
Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
[TBL] [Abstract][Full Text] [Related]
7. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
McIver C; Hogan T; White P; Tapsall J
Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
[TBL] [Abstract][Full Text] [Related]
8. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
9. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia].
Tao CM; Lü XJ; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091
[TBL] [Abstract][Full Text] [Related]
10. Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan.
Huang TM; Chang YF; Chang CF
Vet Microbiol; 2004 Jun; 100(3-4):247-54. PubMed ID: 15145503
[TBL] [Abstract][Full Text] [Related]
11. grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin- methicillin-resistant Staphylococcus aureus.
Coskun-Ari FF; Bosgelmez-Tinaz G
Eur J Med Res; 2008 Aug; 13(8):366-70. PubMed ID: 18952518
[TBL] [Abstract][Full Text] [Related]
12. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
13. Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis.
Betanzos-Cabrera G; Juárez-Verdayes MA; González-González G; Cancino-Díaz ME; Cancino-Díaz JC
Ophthalmic Res; 2009; 42(1):43-8. PubMed ID: 19478540
[TBL] [Abstract][Full Text] [Related]
14. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.
Shultz TR; White PA; Tapsall JW
Antimicrob Agents Chemother; 2005 May; 49(5):1753-60. PubMed ID: 15855492
[TBL] [Abstract][Full Text] [Related]
15. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
Liu YH; Kuo SC; Lee YT; Chang IC; Yang SP; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
17. A nucleotide mutation associated with fluoroquinolone resistance observed in gyrA of in vitro obtained Rhodococcus equi mutants.
Niwa H; Hobo S; Anzai T
Vet Microbiol; 2006 Jun; 115(1-3):264-8. PubMed ID: 16563665
[TBL] [Abstract][Full Text] [Related]
18. Rapid assay for detecting gyrA and parC mutations associated with fluoroquinolone resistance in Enterobacteriaceae.
Nakano R; Okamoto R; Nakano A; Nagano N; Abe M; Tansho-Nagakawa S; Ubagai T; Kikuchi-Ueda T; Koshio O; Kikuchi H; Ono Y
J Microbiol Methods; 2013 Sep; 94(3):213-6. PubMed ID: 23816531
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance-determining region mutations.
Tiejun Z; Xiaoming Z; Jilun Z; Yinghu Z; Yanhua R; Yue C; Weiming G; Tao Z; Qingwu J
Indian J Med Res; 2009 Jun; 129(6):701-6. PubMed ID: 19692753
[TBL] [Abstract][Full Text] [Related]
20. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
